University of Southern Denmark
π©π°Denmark
- Country
- π©π°Denmark
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sdu.dk
Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism
Phase 4
Completed
- Conditions
- Healthy
- First Posted Date
- 2006-11-08
- Last Posted Date
- 2008-02-06
- Lead Sponsor
- University of Southern Denmark
- Target Recruit Count
- 16
- Registration Number
- NCT00397059
- Locations
- π©π°
Clinical Pharmacology, University of Southern Denmark, Odense, Denmark
Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- University of Southern Denmark
- Target Recruit Count
- 200
- Registration Number
- NCT00125645
- Locations
- π©π°
Kardiologisk Klinik, Centralsygehuset Esbjerg/Varde, Esbjerg, Denmark
Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
Phase 4
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2005-08-05
- Lead Sponsor
- University of Southern Denmark
- Target Recruit Count
- 186
- Registration Number
- NCT00124397
- Locations
- π©π°
Department of Medical Research, SHF Svendborg, Svendborg, Denmark
Β© Copyright 2025. All Rights Reserved by MedPath